Health software · Pharma intelligence
Argon AI
An AI workspace sold to commercial and medical affairs teams inside drug companies. Two founders, a Y Combinator batch, a seed round fully sold thirteen months before it was announced, and a customer list still mostly unnamed.
Long division
Randy Guzman is a partner and chief operating officer at Basis Health, a consultancy whose people turn medical literature, trial registries and physician interviews into answers for drug companies. In 2025 his firm put a piece of software called Argon across the whole practice. Asked what changed, he reached for arithmetic.
“This must have been how people felt when the first calculator was invented, and you realize I’ve spent all this time doing long division.”
That line is the pitch for an entire category of software now being sold into pharma. The long division is real. Whether the calculator works as advertised is a separate question, and the public record on it is thin.
The problem
A commercial or medical affairs team inside a drug company is asked, constantly, to answer questions with no single source. Which competitor has a readout in this indication next year. What did the label change actually say. Where is the deck we wrote on this market eighteen months ago.
The inputs sit in trial registries, journals, conference abstracts, regulatory filings, equity research and the company’s own SharePoint, mostly as PDFs and slides. Argon’s release says commercial and medical affairs teams process tens of thousands of documents a year, and that “nearly half of pharmaceutical executives report making decisions with incomplete or outdated information”. It cites no source for that, nor for its headline statistic that “Internal data at pharmaceutical companies now doubles every two years”, which SiliconANGLE reported the same day as doubling annually. For a company selling thoroughness, the provenance of its own market numbers is fair to ask about.
A lawyer and an engineer
Samy Danesh is a lawyer by training, with a JD from the University of Washington, who started at Amazon and then joined Flatiron Health, the oncology data company Roche acquired in 2018. There he led the first analytics services pilot with a large biopharma customer, work that grew into a business unit, and by his own account carried more than $6 million in annual recurring revenue. He watched, from the inside, how the answers got made.
Cyrus Jia is the engineer: products from zero at companies from pre-seed to unicorn, trade generation systems at Bridgewater Associates, a dual degree in electrical engineering and computer science from USC. On his personal site he describes an operating system where humans and AI systems work side by side on research, writing and coordination.
They incorporated in Delaware in 2023, went through Y Combinator’s Winter 2024 batch with Jared Friedman as partner, and set up in Brooklyn. The YC profile still lists a team size of two.
What it actually sells
Argon sells a workspace, not a database, although it ships with one. It connects to the systems a pharma team already uses, Snowflake, SharePoint, Box and Veeva among them, and adds its own continuously updated collection of clinical and commercial sources. On top sit agents the customer configures for competitive tracking, trial benchmarking, market research transcription and provider analysis.
One line on the company site matters more than the rest. Argon says it provides access to “proprietary Sell-side Analyst Research from over 50 leading healthcare banks”. Sell-side equity research is licensed, costly and tightly controlled. Nothing public describes how that access is licensed, from whom, or what a customer may do with it downstream. For a product whose promise is a defensible corpus, that is the load-bearing detail nobody has published.
The thirteen month gap
Argon announced a $5.5 million seed round on July 2, 2025, co-led by Crosslink Capital and Wireframe Ventures with Y Combinator and Pioneer Fund taking part. The SEC record runs longer. Argon AI, Inc. filed a Form D on June 13, 2024 reporting a first sale on May 31, 2024 and an offering of $5,515,000 already sold in full to 31 investors. The money had been in the bank thirteen months when the press release went out.
Nothing about that is irregular. Companies file quietly and announce when they have a story. What Argon had to tell, a year later, was Basis Health: a firm wide deployment at a real consultancy with its CEO and COO both on the record. That is a harder proof point than a funding number.
What is proven, and what is still claimed
| Evidence | What the record shows | Source type |
|---|---|---|
| SEC Form D | CIK 0002026471, filed Jun 13, 2024. First sale May 31, 2024. $5,515,000 offered and sold in full, $0 remaining, 31 investors, Rule 506(b) equity, none non-accredited. Related persons: the two founders only. Delaware corporation, incorporated 2023. | Public record |
| Named customer | Basis Health, a life sciences consultancy within Basis Global, announced a firm wide rollout on Sep 23, 2025 and named Argon its generative AI partner. Its CEO and COO are both quoted by name. | Partner-stated |
| Unnamed customers | The July 2025 release says Argon is “working with two of the top fifteen global pharmaceutical companies”. Neither has been named since. | Company-stated |
| Reported time saving | The Basis team says Argon “reduces time spent on intensive, insight generating, manual tasks by 40-60%”. No baseline, method, task list or measurement period is published. | Partner-stated |
| Security certification | No SOC 2, HITRUST or ISO 27001 attestation appears on the company site or in any source located as of Sep 23, 2026. A third party software catalog records no compliance claims published for the company. | Not found |
| Data handling | Argon and Basis state that partnership data is “not used for any model training or across the platform” and is encrypted and partitioned from other partners. No independent audit is published. | Company-stated |
| Data licensing | The company advertises “proprietary Sell-side Analyst Research from over 50 leading healthcare banks”. No bank is named and no licensing terms appear anywhere public. | Not found |
| Accuracy | The product is marketed on answers that “outperform general LLMs or search engines”. No benchmark, error rate or third party test has been published. | Not found |
| Aggregator funding totals | One startup database reports $12.0M across three rounds and attaches investor names in no SEC filing and no Argon announcement. The SEC record shows a single offering of $5,515,000. | Differs from the record |
| Regulated product records | No FDA 510(k) or PMA record, registered trial, NIH or NSF award, or PubMed paper names the company, checked Sep 23, 2026. | Public record |
Read plainly: the money is verified, the founders are verified, and one customer is verified by name with its own executives attached. Everything a buyer would use to compare Argon against Citeline, Evaluate or an in-house team, meaning accuracy, security attestation, pricing and the provenance of the licensed corpus, is still company-stated or absent. That is ordinary at seed stage. It is also the list a pharma procurement team will ask for.
What to watch
- A second Form D. One has been filed since incorporation, in June 2024. Any round after that must be reported within 15 days of first sale.
- Names for the two top fifteen pharma customers, or a renewal disclosed by one of them.
- A published SOC 2 Type II or equivalent attestation. Enterprise pharma procurement usually requires one before a firm wide rollout, not after.
- Where the sell-side analyst research comes from and on what licence, since that corpus is the part a competitor cannot rebuild with public data.
- Any published accuracy measurement, and any stated method behind the 40 to 60 percent time saving Basis reports. Medical, legal and regulatory reviewers will want both.
In their words
“Every commercial or clinical strategy decision is built on top of fragmented, outdated, or hard-to-access information.”
Samy Danesh, CEO and co-founder, July 2025 funding release · Company release
“We envision a future where AI handles many of the manual, data-intensive tasks so that people are free to interact with insights rather than wrangle with data.”
Samy Danesh, to SiliconANGLE, July 2, 2025 · Independent
“After years inside pharmaceutical and real-world-evidence teams, I’ve seen how much human talent is squandered on data curation and insight generation.”
Samy Danesh, Basis Health partnership release, September 2025 · Company release
“You’re talking about hundreds of hours of manual labor done in minutes.”
Randy Guzman, partner and COO, Basis Health, July 2025 release · Partner-stated
“Our partnership with Argon has enabled our teams to go faster while gleaning deeper insights while developing deeper strategic thinking”
Paul Eccles, CEO, Basis Health, September 2025 · Partner-stated
“The life sciences industry has been ripe for this kind of transformation for over a decade.”
Phil Boyer, partner, Crosslink Capital, July 2025 release · Investor, company release
Related companies
Sources
- Public recordForm D, Argon AI, Inc., CIK 0002026471
- Public recordFDA 510(k) and PMA device databases, no record naming the company
- Public recordClinicalTrials.gov, NIH RePORTER, NSF awards and PubMed, no record naming the company
- IndependentArgon AI raises $5.5M to build AI-native workspace for biopharma teams
- IndependentArgon AI raises $5.5M for product improvement, team growth
- IndependentBasis Health Taps Argon AI to Cut Consulting Inefficiencies by 40-60%
- IndependentArgon reviews, security and pricing, plus company trust profile
- CompanyArgon AI Raises $5.5M to Build the AI Workspace Powering the Future of Life Sciences
- PartnerBasis Health Partners with Argon AI to Build the AI Backbone of Life-Sciences Consulting
- CompanyArgon AI, Inc. company profile and launch post
- CompanyArgon AI website, home, use cases and competitive intelligence pages
- CompanyCyrus Jia personal site
- Differs from the recordArgon AI funding, team and investors listing
Profile researched and written by Healthcare Discovery. Last updated September 29, 2026.
